Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Must be at least 18 of age~* Must meet the criteria for major depressive disorder~* You must be able to visit the doctor's office about once a week for 2 to 3 months. After that, you will need to visit the doctor's office once a month for about 6 months~* You must be able to take the study drug as prescribed (6 capsules per day taken once-daily)~Exclusion Criteria:~* You are a woman and are pregnant or breastfeeding.~* You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.~* You have a history of alcohol or drug dependence within the past 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).